| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| M Bibl, B Mollenhauer, H Esselmann, P Lewczuk, C Trenkwalder, P Brechlin, E Rüther, J Kornhuber, M Otto, J Wiltfan. CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies. Journal of neural transmission (Vienna, Austria : 1996). vol 113. issue 11. 2007-09-05. PMID:16906356. |
differential diagnosis of alzheimer's disease (ad) and dementia with lewy bodies (dlb) is often crucial. |
2007-09-05 |
2023-08-12 |
Not clear |
| R Nardone, A Bratti, F Tezzo. Motor cortex inhibitory circuits in dementia with Lewy bodies and in Alzheimer's disease. Journal of neural transmission (Vienna, Austria : 1996). vol 113. issue 11. 2007-09-05. PMID:17024328. |
to determine whether a peculiar neurophysiological profile may contribute to characterize dementia with lewy bodies (dlb) vs. alzheimer disease (ad), we used transcranial magnetic stimulation to examine the excitability of two different inhibitory systems of the motor cortex, short latency intracortical inhibition (sici) and short latency afferent inhibition (sai) in 10 patients with dlb, in 13 patients with ad and in 15 healthy subjects. |
2007-09-05 |
2023-08-12 |
human |
| M Oinas, R Sulkava, T Polvikoski, H Kalimo, A Paeta. Reappraisal of a consecutive autopsy series of patients with primary degenerative dementia: Lewy-related pathology. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. vol 115. issue 7. 2007-09-05. PMID:17614849. |
dementia with lewy bodies (dlb) is a common but underdiagnosed dementing disorder. |
2007-09-05 |
2023-08-12 |
Not clear |
| M Oinas, R Sulkava, T Polvikoski, H Kalimo, A Paeta. Reappraisal of a consecutive autopsy series of patients with primary degenerative dementia: Lewy-related pathology. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. vol 115. issue 7. 2007-09-05. PMID:17614849. |
we have re-evaluated the neuropathology of 55 autopsied patients with clinically diagnosed primary degenerative dementia to determine the frequency of dlb in this cohort, which was originally examined when neither the entity of dlb nor its diagnostic criteria had been defined. |
2007-09-05 |
2023-08-12 |
Not clear |
| Lori A Daiell. Atypical antipsychotics for the treatment of dementia-related behaviors: an update. Medicine and health, Rhode Island. vol 90. issue 6. 2007-08-29. PMID:17633594. |
studies of small numbers of patients in open trials of cholinesterase inhibitors (donepezil, rivastigmine, galantamine) and one double-blind placebo controlled trial (rivastigmine) have reported varying degrees of improvement of behavioral symptoms and psychosis of dementia with lewy bodies (dlb). |
2007-08-29 |
2023-08-12 |
Not clear |
| M Bibl, B Mollenhauer, P Lewczuk, H Esselmann, S Wolf, C Trenkwalder, M Otto, G Stiens, E Rüther, J Kornhuber, J Wiltfan. Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias. Molecular psychiatry. vol 12. issue 7. 2007-08-28. PMID:17339876. |
biomarkers for differential diagnosis of the three most frequent degenerative forms of dementia, alzheimer's disease (ad), dementia with lewy bodies (dlb) and frontotemporal dementias (ftd), are currently under intensive investigation, but disease-specific biomarkers for ftd and dlb are still lacking. |
2007-08-28 |
2023-08-12 |
human |
| M Bibl, B Mollenhauer, P Lewczuk, H Esselmann, S Wolf, C Trenkwalder, M Otto, G Stiens, E Rüther, J Kornhuber, J Wiltfan. Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias. Molecular psychiatry. vol 12. issue 7. 2007-08-28. PMID:17339876. |
we analyzed 303 cerebrospinal fluid (csf) samples of 71 ad, 32 dlb and 36 ftd patients in comparison to 93 various other dementias (od), 20 peripheral neurologic disease (pnd) controls, 25 neurodegenerative disorders without dementia (nd) and 26 depressive cognitive complainers (dcc) for distinct csf amyloid-beta (abeta) peptide patterns, using the quantitative abeta-sds-page/immunoblot. |
2007-08-28 |
2023-08-12 |
human |
| D Weisman, M Cho, C Taylor, A Adame, L J Thal, L A Hanse. In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology. vol 69. issue 4. 2007-08-20. PMID:17646627. |
we used an autopsy series to determine whether the newest dementia with lewy bodies (dlb) consensus pathologic classification correlates with premortem diagnosis of dlb. |
2007-08-20 |
2023-08-12 |
Not clear |
| Shinji Higashi, Saskia Biskup, Andrew B West, Daniel Trinkaus, Valina L Dawson, Richard L M Faull, Henry J Waldvogel, Heii Arai, Ted M Dawson, Darren J Moore, Piers C Emso. Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain. Brain research. vol 1155. 2007-08-13. PMID:17512502. |
the distribution of lrrk2 in brain tissue from sporadic pd and dementia with lewy bodies (dlb) subjects was also examined. |
2007-08-13 |
2023-08-12 |
human |
| Michael J Firbank, Andrew M Blamire, Mani S Krishnan, Andrew Teodorczuk, Philip English, Anil Gholkar, Roger Harrison, John T O'Brie. Atrophy is associated with posterior cingulate white matter disruption in dementia with Lewy bodies and Alzheimer's disease. NeuroImage. vol 36. issue 1. 2007-08-01. PMID:17412610. |
hippocampal atrophy and posterior cingulate hypometabolism are common features of both alzheimer's disease (ad) and dementia with lewy bodies (dlb). |
2007-08-01 |
2023-08-12 |
human |
| Keith Edwards, Donald Royall, Linda Hershey, David Lichter, Ann Hake, Martin Farlow, Florence Pasquier, Stewart Johnso. Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study. Dementia and geriatric cognitive disorders. vol 23. issue 6. 2007-07-24. PMID:17409748. |
dementia with lewy bodies (dlb) is a common dementia of the elderly. |
2007-07-24 |
2023-08-12 |
Not clear |
| Robert Perneczky, Peter Haussermann, Janine Diehl-Schmid, Henning Boecker, Hans Forstl, Alexander Drzezga, Alexander Kur. Metabolic correlates of brain reserve in dementia with Lewy bodies: an FDG PET study. Dementia and geriatric cognitive disorders. vol 23. issue 6. 2007-07-24. PMID:17457029. |
research has been mainly focussed on alzheimer's disease and no studies exist on patients with dementia with lewy bodies (dlb). |
2007-07-24 |
2023-08-12 |
Not clear |
| Xiongwei Zhu, Asim Babar, Sandra L Siedlak, Qiwei Yang, Genta Ito, Takeshi Iwatsubo, Mark A Smith, George Perry, Shu G Che. LRRK2 in Parkinson's disease and dementia with Lewy bodies. Molecular neurodegeneration. vol 1. 2007-07-16. PMID:17137507. |
to examine whether lrrk2 is directly associated with neuropathology of pd and other related disorders, we analyzed lrrk2 in brains of patients affected by pd and dementia with lewy bodies (dlb) using highly specific antibodies to lrrk2. |
2007-07-16 |
2023-08-12 |
Not clear |
| Luca Rozzini, Barbara Vicini Chilovi, Erik Bertoletti, Marta Conti, Ilenia Delrio, Marco Trabucchi, Alessandro Padovan. Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study. American journal of Alzheimer's disease and other dementias. vol 22. issue 1. 2007-07-16. PMID:17534001. |
cholinesterase inhibitors (cheis) are effective in improving cognition and behavior in patients affected by alzheimer's disease (ad) as well as by lewy bodies dementia (dlb). |
2007-07-16 |
2023-08-12 |
Not clear |
| Luca Rozzini, Barbara Vicini Chilovi, Erik Bertoletti, Marta Conti, Ilenia Delrio, Marco Trabucchi, Alessandro Padovan. Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study. American journal of Alzheimer's disease and other dementias. vol 22. issue 1. 2007-07-16. PMID:17534001. |
the authors compared the effect of rivastigmine in the treatment of cognitive impairment and behavioral and psychological symptoms of dementia (bpsd) in 30 ad and in 30 dlb patients. |
2007-07-16 |
2023-08-12 |
Not clear |
| Shino Magaki, Ravi Raghavan, Claudius Mueller, Kerby C Oberg, Harry V Vinters, Wolff M Kirsc. Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias. Neuroscience letters. vol 418. issue 1. 2007-07-12. PMID:17408857. |
in this pilot study we extracted and measured the levels of loosely bound, non-heme and total iron and copper in the frontal cortex and hippocampus of patients with mild-moderate ad (n=3), severe ad (n=8) and dementia with lewy bodies (dlb, n=6), using graphite furnace atomic absorption spectrometry (gfaas). |
2007-07-12 |
2023-08-12 |
Not clear |
| James E Galvin, Heather Malcom, David Johnson, John C Morri. Personality traits distinguishing dementia with Lewy bodies from Alzheimer disease. Neurology. vol 68. issue 22. 2007-07-12. PMID:17536045. |
to identify personality traits that distinguish dementia with lewy bodies (dlb) from alzheimer disease (ad). |
2007-07-12 |
2023-08-12 |
Not clear |
| L M Allan, C G Ballard, J Allen, A Murray, A W Davidson, I G McKeith, R A Kenn. Autonomic dysfunction in dementia. Journal of neurology, neurosurgery, and psychiatry. vol 78. issue 7. 2007-07-09. PMID:17178816. |
there are no studies of autonomic function comparing alzheimer's disease (ad), vascular dementia (vad), dementia with lewy bodies (dlb) and parkinson's disease dementia (pdd). |
2007-07-09 |
2023-08-12 |
Not clear |
| K Mondon, A Gochard, A Marqué, A Armand, D Beauchamp, C Prunier, D Jacobi, B de Toffol, A Autret, V Camus, C Homme. Visual recognition memory differentiates dementia with Lewy bodies and Parkinson's disease dementia. Journal of neurology, neurosurgery, and psychiatry. vol 78. issue 7. 2007-07-09. PMID:17287240. |
to compare cognitive impairments in dementia with lewy bodies (dlb) and parkinson's disease dementia (pdd), to discriminate between the two entities. |
2007-07-09 |
2023-08-12 |
Not clear |
| M Saldaña, J Mullol, E Aguilar, M Bonastre, C Mari. Nuclear factor kappa-B p50 and p65 subunits expression in dementia with Lewy bodies. Neuropathology and applied neurobiology. vol 33. issue 3. 2007-07-06. PMID:17442064. |
dementia with lewy bodies (dlb) is the second most common cause of neurodegenerative dementia after alzheimer's disease (ad). |
2007-07-06 |
2023-08-12 |
human |